Gabelli Funds LLC Sells 200 Shares of STERIS plc (NYSE:STE)

Gabelli Funds LLC trimmed its position in STERIS plc (NYSE:STE) by 0.9% in the 4th quarter, HoldingsChannel reports. The fund owned 23,000 shares of the medical equipment provider’s stock after selling 200 shares during the quarter. Gabelli Funds LLC’s holdings in STERIS were worth $4,728,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in STE. Avalon Trust Co purchased a new stake in shares of STERIS in the fourth quarter worth $30,000. Human Investing LLC bought a new position in STERIS in the 4th quarter worth $31,000. Anfield Capital Management LLC increased its stake in STERIS by 100.0% in the 4th quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider’s stock worth $37,000 after buying an additional 91 shares in the last quarter. Central Pacific Bank Trust Division raised its holdings in STERIS by 65.5% during the fourth quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider’s stock valued at $39,000 after acquiring an additional 76 shares during the period. Finally, Manchester Capital Management LLC lifted its position in shares of STERIS by 182.7% in the fourth quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider’s stock valued at $44,000 after acquiring an additional 137 shares in the last quarter. Institutional investors own 94.69% of the company’s stock.

STERIS Stock Performance

NYSE STE opened at $222.53 on Friday. The stock has a market capitalization of $21.86 billion, a PE ratio of 47.25 and a beta of 0.87. STERIS plc has a 1-year low of $197.84 and a 1-year high of $248.24. The business has a 50 day simple moving average of $222.50 and a two-hundred day simple moving average of $219.28. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.13 and a quick ratio of 1.40.

STERIS (NYSE:STE) last posted its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share for the quarter, missing analysts’ consensus estimates of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. On average, research analysts predict that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, March 21st. Investors of record on Thursday, February 20th were issued a $0.57 dividend. This represents a $2.28 dividend on an annualized basis and a dividend yield of 1.02%. The ex-dividend date was Thursday, February 20th. STERIS’s payout ratio is 48.41%.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on STE shares. Needham & Company LLC reissued a “hold” rating on shares of STERIS in a research note on Monday, April 7th. Stephens reaffirmed an “overweight” rating and set a $240.00 price objective on shares of STERIS in a report on Thursday, February 6th. Piper Sandler boosted their target price on shares of STERIS from $260.00 to $265.00 and gave the stock an “overweight” rating in a report on Monday, February 3rd. Finally, JMP Securities reaffirmed a “market outperform” rating and set a $265.00 target price on shares of STERIS in a research note on Thursday, April 10th. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $258.75.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.